Drug companies are getting $50K+ for cancer drugs that extend survival by six months, even though the patient still dies. A new vaccine for prostate cancer that extends survival by four months in clinical trials has been priced at $90K, and will likely get it. A drug that completely cured advanced breast cancer, say, would command $300K easy. Easy. They are often biologics which have, so far, not faced much generic competition.
Diabetes drugs like Actos, Avandia, Byetta cost appx $100-200/mo or $12-24K/yr. And the patent lives run out 7-10 yrs after the drug makes it to market so the drug company doesn't get that price for the patient's lifetime, only until the drug goes generic.
The financial reward of a successful cancer drug is very high. See the stock prices of oncology-focused drug and biotech companies.
True, the mythical $1K drug that cures all cancer would be a calamity, economically speaking, for drug companies. But I think that is so far off that there's no need for conspiracy theories yet.
Quote:
|
Quote de jyl
The drug industry spends a huge amount of money looking for cancer treatments (pricing can be very good for oncology drugs).
Treatments is the operative word. My cousin is one of Australia's leading micro biologists and although oncology is not her field she finds herself dealing with all sorts of Drs. regularly. She said the same thing Z-Man said. If you treat the disease you have an income for life. If you cure it, your cash cow dries up.
Maybe this bloke is onto something??
YouTube - 1- Sodium bicarbonate, a natural way to treat the cancer
|